Legal attitude: Art. 17 para. 1 MAR - confidential information. Br> The Management Board of Biogened S.A. (hereinafter the "Issuer") informs that on 8 September 2017, the issue of 5,000 ordinary bearer bonds series BGD0920 with a nominal value of PLN 1,000.00 (one thousand zlotys) took place each bond and the total nominal value of 5,000,000, PLN 00 (five million zlotys). The issue was carried out in the mode of art. 33 point 2) of the Act on bonds on the basis of the resolution of the Issuer's Management Board No. 19/2017 of August 18, 2017 regarding the issue of bonds series BGD0920. The bonds were subscribed at the issue price equal to the nominal value. The bond redemption day is September 8, 2020. The bonds bear interest and the interest rate is variable according to the WIBOR 3M rate plus a margin and, starting from the second interest period, increased by additional remuneration, the amount of which will depend on the value of the leverage ratio. The bonds do not have the form of a document. Until registration of the Bonds in the securities depository maintained by Krajowy Depozyt Papierów Wartościowych SA, the activities related to keeping the records of the Bonds and making payments on the Bonds on behalf of the Issuer were entrusted to Alior Bank SA Subject to registration at KDPW SA, the Issuer will apply for introduction BGD0920 series bonds for trading in the alternative trading system on the Catalyst market run by Giełda Papierów Wartościowych w Warszawie SA or Bondspot S.A. br> In the opinion of the Issuer's Management Board, the above information constitutes confidential information within the meaning of art. 7 of the MAR Regulation concerning the Issuer, which, if made public, may have a significant impact on the price of its financial instruments. Br>
Source: company website, investor relations, current and periodic reports.